Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00307190 · ClinicalTrials.gov registry record
Hormone Release and Stomach Disturbances in People With Binge Eating Disorder
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 24
- Enrollment target
NCT00307190: Completed study, sponsored by New York State Psychiatric Institute.
NCT00307190 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00307190 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This study will determine whether the disturbances in cholecystokinin release and gastric emptying that occur in people with binge eating disorder are similar to those that occur in people with bulimia nervosa.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-10 |
| Est. Completion | 2009-10 |
What the finished NCT00307190 record still lists
NCT00307190 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00307190 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00307190 about?
NCT00307190 is a clinical study titled "Hormone Release and Stomach Disturbances in People With Binge Eating Disorder". This study will determine whether the disturbances in cholecystokinin release and gastric emptying that occur in people with binge eating disorder are similar to those that occur in people with bulimia nervosa.
What is the current status of trial NCT00307190?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2004-10. Estimated completion is 2009-10.
Who is sponsoring clinical trial NCT00307190?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia